Back | Next |
home / stock / mcrb / mcrb message board
Subject | By | Source | When |
---|---|---|---|
========================= | Extremist223 | investorshub | 08/08/2022 7:16:41 PM |
No rebuttal? Is this market even worldwide? Or | Extremist223 | investorshub | 06/11/2022 9:12:02 PM |
I don't know why pharma wouldn't short this | Extremist223 | investorshub | 06/10/2022 6:27:47 PM |
I'm not saying I would have played it, | swingingRichard | investorshub | 10/19/2020 2:47:43 AM |
$MCRB is a great $$$$$ opportunity. | crudeoil24 | investorshub | 08/14/2020 6:28:50 PM |
Current shelf placement closes Monday, and generates over | crudeoil24 | investorshub | 08/14/2020 6:28:21 PM |
* * $MCRB Video Chart 08-13-2020 * * | ClayTrader | investorshub | 08/13/2020 8:26:20 PM |
* * $MCRB Video Chart 08-10-2020 * * | ClayTrader | investorshub | 08/10/2020 8:54:30 PM |
$MCRB Asset Accumulation | davidsson10 | investorshub | 08/10/2020 8:01:50 PM |
This is $HUGE... I am an NP so | rlangmaid | investorshub | 08/10/2020 7:38:01 PM |
Whats the price target here? Yes | CyrusDaVirus | investorshub | 08/10/2020 4:57:17 PM |
73k CDI episodes of 2+ recurrences/year in US | chuckgray | investorshub | 08/10/2020 4:18:47 PM |
$MCRB discovers immortality = stock quadruples lol | $treet $inatra | investorshub | 08/10/2020 2:02:29 PM |
Good grief chief $$$$$$$$$$$$ | Golden Cross | investorshub | 08/10/2020 12:18:38 PM |
$MCRB @ 19.39 up 317% > | crudeoil24 | investorshub | 08/10/2020 12:01:16 PM |
16.95 up 275% in PM. > FDA phase | crudeoil24 | investorshub | 08/10/2020 11:39:42 AM |
Seres Therapeutics Phase 3 SER-109 Study Meets Main | crudeoil24 | investorshub | 08/10/2020 11:14:42 AM |
* * $MCRB Video Chart 06-29-2019 * * | ClayTrader | investorshub | 06/29/2019 7:49:26 PM |
Rebound continues here | Golden Cross | investorshub | 06/25/2019 1:15:25 PM |
* * $MCRB Video Chart 06-14-2019 * * | ClayTrader | investorshub | 06/14/2019 8:38:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Seres Therapeutics Inc. Company Name:
MCRB Stock Symbol:
NASDAQ Market:
Seres Therapeutics Inc. Website:
Clinical data readout expected end of Q3 2024 SER-155 and other Seres microbiome therapeutic candidates have potential to expand microbiome therapeutic franchise into additional medically vulnerable patient populations Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiom...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
VOWST net sales of $10.4 million for the fourth quarter of 2023 and $19.6 million since launch in June through year-end 2023 Significant adoption of VOWST since launch in June 2023 through year-end 2023 with 2,833 patient enrollment forms received and 2,015 new patient starts ...